10x Genomics, Inc. (TXG)

19,59 -0,29 (-1,46 %) À la clôture : 04:00PM EDT

10x Genomics, Inc.

6230 Stoneridge Mall Road
Pleasanton, CA 94588-3260
United States
925 401 7300
https://www.10xgenomics.com

Secteur(s): Healthcare
Secteur d’activité: Health Information Services
Employés à temps plein: 1 259

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Dr. Serge Saxonov Ph.D.	Co-Founder, CEO & Director	925,05k	1,98M	1977
Dr. Benjamin J. Hindson Ph.D.	Co-Founder, President, Chief Scientific Officer & Director	618,32k	1,5M	1975
Mr. Justin J. McAnear	Chief Financial Officer	587,41k	S.O.	1976
Mr. Eric S. Whitaker Esq.	Chief Legal Officer	615,38k	3,19M	1967
Mr. Michael Schnall-Levin	Founding Scientist & CTO	S.O.	S.O.	S.O.
Ms. Cassie Corneau	Manager of Investor Relations and Strategic Finance	S.O.	S.O.	S.O.
Ms. Rebecca Port	Chief People Officer	S.O.	S.O.	S.O.
Mr. Jens Durruthy	Associate Director of Product Management	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Gouvernance d’entreprise

L’ISS Governance QualityScore de 10x Genomics, Inc. en date du 1 juin 2024 est 8. Les scores principaux sont Audit : 3; Société : 6; Droits des actionnaires : 10; Compensation : 7.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.